41 /100
MEDIUM RISK
Score updated Jul 14, 2026

RGC — Regencell Bioscience Holdings Limited Dilution Risk Tracker

Track RGC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RGC — Get alerts when the score changes →

As of July 14, 2026, Regencell Bioscience Holdings Limited (RGC) has a DilutionWatch DilutionScore of 41/100, rated MEDIUM dilution risk. Regencell Bioscience Holdings Limited has a market capitalization of $11.82B, 494.49M shares outstanding, 35 institutional holders tracked. Key dilution vectors include approximately 34 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
67
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for RGC.
🔔 Track RGC — Get forecast alerts →

💹 Market Data

Market Cap$11.82B
Shares Outstanding494.49M
Float55.41M
Cash$8.89M
Debt$3.00M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 32.8% shares (2026Q1 vs prior)
35 institutional holders · 878.0K shares
#1 GEODE CAPITAL MANAGEMENT, LLC 415.6K shares
#2 MORGAN STANLEY 79.3K shares
#3 SUSQUEHANNA INTERNATIONAL GROUP, LLP 72.7K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest760.8K
Days to Cover2.0
% of Float1.4%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Jun 30, 2022
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for RGC Shareholders

Regencell Bioscience Holdings Limited (RGC) has a DilutionScore of 41/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for RGC shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for RGC in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for RGC alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track RGC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RGC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for RGC
📊 RGC FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 RGC Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.